P1172: ARTIFICIAL INTELLIGENCE FOR PROGNOSIS PREDICTION OF NATURAL KILLER/T-CELL LYMPHOMA BASED ON MAGNETIC RESONANCE IMAGING

• Qingqing Cai,
• Chaofeng LI,
• Liang Wang,
• Chuanmiao Xie,
• Yuchen Zhang,
• Yishu Deng,
• Qihua Zou,
• Bingzhong Jing,
• Peiqiang Cai,
• Xiaopeng Tian,
• Yi Cao,
• Yu Yang,
• Bingzong LI,
• Fang Liu,
• Zhihua LI,
• Zaiyi Liu,
• Shiting Feng,
• Tingsheng Peng,
• Yujun Dong,
• Xinyan Wang,
• Guangying Ruan,
• Yun He,
• Huiqiang Huang,
• Yang Liang

Affiliations

Qingqing Cai

1 Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine,Guangzhou, P. R. China

Chaofeng LI

1 Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine,Guangzhou, P. R. China

Liang Wang

4 Beijing Tongren Hospital, Capital Medical University, Department of Hematology, Beijing, P. R. China.

Chuanmiao Xie

1 Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine,Guangzhou, P. R. China

Yuchen Zhang

1 Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine,Guangzhou, P. R. China

Yishu Deng

1 Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine,Guangzhou, P. R. China

Qihua Zou

1 Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine,Guangzhou, P. R. China

Bingzhong Jing

1 Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine,Guangzhou, P. R. China

Peiqiang Cai

1 Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine,Guangzhou, P. R. China

Xiaopeng Tian

1 Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine,Guangzhou, P. R. China

Yi Cao

1 Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine,Guangzhou, P. R. China

Yu Yang

7 Fujian Provincial Cancer Hospital & Institute,Department of Lymphadenoma and Head & Neck Medical Oncology,Fuzhou, P. R. China

Bingzong LI

8 The Second Affiliated Hospital of Suzhou University,Department of Hematology, Suzhou，P. R. China.

Fang Liu

9 The First People’s Hospital of Foshan, Department of Pathology, Foshan, P. R. China

Zhihua LI

10 Sun Yat-sen Memorial Hospital, Department of Oncology, Guangzhou, P. R. China

Zaiyi Liu

11 Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University,Department of Radiology, Guangzhou, P.R. China

Shiting Feng

13 The First Affiliated Hospital, Sun Yat-Sen University, Department of Radiology, Guangzhou, P. R. China

Tingsheng Peng

14 The First Affiliated Hospital of Sun Yat-sen University, Department of Pathology, Guangzhou, P. R. China

Yujun Dong

15 Peking University First Hospital, Department of Hematology, Beijing, P.R. China

Xinyan Wang

16 Beijing Tongren Hospital, Capital Medical University, Department of Radiology, Beijing, P. R. China

Guangying Ruan

1 Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine,Guangzhou, P. R. China

Yun He

1 Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine,Guangzhou, P. R. China

Huiqiang Huang

1 Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine,Guangzhou, P. R. China

Yang Liang

1 Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine,Guangzhou, P. R. China